STAT - Reporting from the frontiers of health and medicine

In the Lab

First Opinion

By Spencer Phillips Hey

Biotech

Politics Tracking Washington’s moves on drug pricing
Live Chat Archived: An online chat discussing the past — and future — of Alzheimer’s research
First Opinion Personalized treatments may be threatened by drug cost-containment proposals
Pharmalot Novartis sets aside $700 million to settle long-running bribery allegations in the U.S.
Health WHO declares Ebola outbreak an international health emergency

Exclusive analysis of biotech, pharma, and the life sciences

Daily, market-moving coverage of biotech and pharma

Inside intelligence on the NIH, the FDA, and Congress

Profiles of the power players shaping the industry

Analysis of the latest scientific developments

Alector, with big ideas about treating dementia, presents a little bit of data
An Indian drug maker sent records to its scrapyard before the FDA visited
Pharmalittle: Women make ‘little progress’ in key pharma roles; FDA approves a Merck antibiotic

Special Report

Heavyweights

Biotech

Biotech

Health

Health

First Opinion A bird’s-eye view of clinical trials provides new perspectives on drug research and development
In the Lab Do Elon Musk’s brain-decoding implants have potential? Experts say they just might
Health WHO declares Ebola outbreak an international health emergency
Health Tech An experimental AI system can predict when pancreatic cysts will become cancerous
Special Report How pharma, under attack from all sides, keeps winning in Washington